Project title: Development of innovative formulations of biologically active compounds with increased oral bioavailability.
Aim of the project: The aim of the project is to develop a novel oral delivery product for lipophilic active compounds from the cannabinoid group with improved bioavailability, absorption and convenience route of ingestion.
Total budget: 4 241 999,13 PLN | Funding value: 3 226 079,98 PLN
Duration of the project: 1 December 2021 – 31 December 2023
Project contribution of European Funds
The project is co-financed from the European Regional Development Fund under Priority Axis III - Support for innovation in enterprises; Measure: 3.3. Support for innovation in enterprises; Measure: 3.3 Support for promotion and internationalisation of innovative enterprises, Operational Programme Intelligent Development 2014-2020; Contract no: UG-PMT/3342/1N/2022-USA Polish Bridges of Technology.
Healthcann S.A.
ul. Klecińska 123, 54-413 Wrocław
VAT No: 894 31 54 198
KRS: 0000979833